May gindugang ang Food and Drug Administration (FDA) nga mga bulong sa lista sang VAT-exempt medicines.
Suno sa advisory sang ahensya, yari ang ila bag-o nga ginbutang sa listahan:
Cancer Medicine
Degarelix: Freeze-dried powder for solution for injection (80 mg and 120 mg)
Tremelimumab: Concentrate for solution for infusion (25 mg/1.25 mL, 20 mg/mL)
Diabetes Medicine
Sitagliptin: Film-coated tablet (25 mg, 50 mg, 100 mg)
Sitagliptin (as hydrochloride) + Metformin Hydrochloride: Film-coated tablet (50 mg/1 g, 50 mg/850 mg)
Sitagliptin (as hydrochloride monohydrate): Film-coated tablet (25 mg, 50 mg)
Linagliptin: Film-coated tablet (5 mg)
Medicine for Mental Illness
Clomipramine Hydrochloride: Film-coated tablet (25 mg)
Chlorpromazine (as hydrochloride): Tablet (200 mg)
Midazolam: Film-coated tablet (15 mg)
Ginpaathag naman ni FDA spokesperson Atty. Pamela Sevilla nga ini nga mga bag-o nga mga bulong nga gindugang sa lista ang gindesisyunan sang mga tiglawas sang FDA, Department of Health (DOH), Department of Finance, kag Bureau of Internal Revenue matapos nga ang business nag-apply para sa VAT-exempt sa ila kumpaniya.
“VAT exempt medicines is in line with our national internal revenue code po or tax code, which was amended by our train law, and was eventually amended by the CREATE law,” suno kay Sevilla.
Regular ang pag-update sa listahan suno sa natungdan kag may iban naman nga bulong nga ginakakas na.
Sang Agusto, nag-anunsyo man ang FDA sang 15 cancer, high cholesterol, hypertension, kag mental illness medicines bilang VAT-exempt.
